|
|
| A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Neo Comprehensive - Solid Tumor (plus PD-L1)
Test CodeLAB6600
CPT Codes
81455x1. Add 88360x1 for PD-L1 IHC.
Preferred Specimen
A block is preferred for testing: ≥20% tumor and ≥10 mm² of tissue surface area for NGS (~500 tumor cells)
(if PD-L1 is ordered, at least 100 neoplastic cells are required)
If submitting 5 μm unstained slides, the following number of slides are requested:
(if PD-L1 is ordered, at least 100 neoplastic cells are required)
If submitting 5 μm unstained slides, the following number of slides are requested:
- Samples with ≥ 25 mm² of tissue: 10 unstained slides (2 sections per slide preferred)
- Samples with 10-24 mm² of tissue: 20 unstained slides (2 sections per slide preferred)
Transport Container
Use cold pack for transport, making sure cold pack is not in direct contact with specimen.
Report Available
8-10 days
Clinical Significance
Neo Comprehensive - Solid Tumor detects genomic alterations that are most relevant to diagnosis, therapy selection, prognosis, and clinical trial options in solid tumors. It Is appropriate for patients with newly diagnosed, recurrent, or resistant disease.
Performing Laboratory
Neogenomics Laboratories
